What's new

Human medicines European public assessment report (EPAR): Onureg, azacitidine, Date of authorisation: 17/06/2021, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Onureg, azacitidine, Date of authorisation: 17/06/2021, Revision: 2, Status: Authorised

Feb 18, 2025 - 10:57
 0
Human medicines European public assessment report (EPAR): Onureg, azacitidine, Date of authorisation: 17/06/2021, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Onureg, azacitidine, Date of authorisation: 17/06/2021, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Basilea opts not to take MRSA antibiotic into clinic due to ‘stringent risk-retu...

Next Article

UK court approves £3bn Thames Water loan

Related Posts

Human medicines European public assessment report (EPAR): Dimethyl fumarate Accord, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 14, 2025  0

Haematology Working Party

Haematology Working Party

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 11, 2025  0